Pfizer (PFE) stock in focus as its hemophilia drug Hympavzi succeeds in a Phase 3 trial. Read more here.

Garrett Brings More Than 20 Years of Accounting and Financial Reporting Experience to the Newly Established RoleBIRMINGHAM, Ala., July 02, 2025 (GLOBE NEWSWIRE) -- Diversified Energy Company PLC (LSE: ...

The hedge fund, one of the industry's busiest activist investors, said it will engage with Tripadvisor's management about ...

A trader works on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., July 11, 2025. REUTERS/Jeenah Moon/File Photo Losses in Wall Street futures dragged Asian stocks lower on ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

Intercontinental Exchange will add Texas as its venue for secondary listing, the NYSE owner with a market value of $102 billion said on Monday as it prepares to compete with the Texas Stock ...

Mr. Mahatme brings decades of experience in strategic finance, capital formation, and operational leadership to support ...

US regulators approved Moderna Inc.’s COVID-19 vaccine for children, but for a narrower group than before, continuing Robert ...

Shares of this biotech giant have lost 16.3% year to date compared with the industry’s decline of 2.7%. The sto ...

Barron’s has long favored dividend-paying stocks for those seeking income. But bonds now deserve a hard look because they are ...